| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.9 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.9 |